| Preclinical characterization of abemaciclib in hormone receptor positive breast cancer R Torres-Guzmán, B Calsina, A Hermoso, C Baquero, B Alvarez, J Amat, ... Oncotarget 8 (41), 69493, 2017 | 194 | 2017 |
| Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-prono study): a European network for the study of adrenal tumors retrospective study S Hescot, M Curras-Freixes, T Deutschbein, A van Berkel, D Vezzosi, ... The Journal of Clinical Endocrinology & Metabolism 104 (6), 2367-2374, 2019 | 170 | 2019 |
| Gain-of-function mutations in DNMT3A in patients with paraganglioma L Remacha, M Currás-Freixes, R Torres-Ruiz, F Schiavi, R Torres-Pérez, ... Genetics in Medicine 20 (12), 1644-1651, 2018 | 106 | 2018 |
| Recurrent germline DLST mutations in individuals with multiple pheochromocytomas and paragangliomas L Remacha, D Pirman, CE Mahoney, J Coloma, B Calsina, ... The American Journal of Human Genetics 104 (4), 651-664, 2019 | 94 | 2019 |
| PheoSeq: a targeted next-generation sequencing assay for pheochromocytoma and paraganglioma diagnostics M Currás-Freixes, E Piñeiro-Yañez, C Montero-Conde, M Apellániz-Ruiz, ... The Journal of molecular diagnostics 19 (4), 575-588, 2017 | 83 | 2017 |
| Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients B Calsina, M Currás-Freixes, A Buffet, T Pons, L Contreras, R Letón, ... Genetics in Medicine 20 (12), 1652-1662, 2018 | 73 | 2018 |
| Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma B Calsina, LJ Castro-Vega, R Torres-Pérez, L Inglada-Pérez, ... Theranostics 9 (17), 4946, 2019 | 65 | 2019 |
| Sino-European differences in the genetic landscape and clinical presentation of pheochromocytoma and paraganglioma J Jiang, J Zhang, Y Pang, N Bechmann, M Li, M Monteagudo, B Calsina, ... The Journal of Clinical Endocrinology & Metabolism 105 (10), 3295-3307, 2020 | 61 | 2020 |
| HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas N Bechmann, ML Moskopp, M Ullrich, B Calsina, PW Wallace, S Richter, ... Endocrine-related cancer 27 (11), 625-640, 2020 | 58 | 2020 |
| Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma G Eisenhofer, T Deutschbein, G Constantinescu, K Langton, C Pamporaki, ... Clinical Chemistry and Laboratory Medicine (CCLM) 59 (2), 353-363, 2021 | 55 | 2021 |
| Genetic bases of pheochromocytoma and paraganglioma A Cascón, B Calsina, M Monteagudo, S Mellid, A Díaz-Talavera, ... Journal of Molecular Endocrinology 70 (3), 2023 | 48 | 2023 |
| Genomic and immune landscape of metastatic pheochromocytoma and paraganglioma B Calsina, E Piñeiro-Yáñez, ÁM Martínez-Montes, E Caleiras, ... Nature communications 14 (1), 1122, 2023 | 46 | 2023 |
| Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome JM Roldan-Romero, M Santos, J Lanillos, E Caleiras, G Anguera, ... Modern Pathology 33 (12), 2580-2590, 2020 | 43 | 2020 |
| Succinate Mediates Tumorigenic Effects via Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient … DM Matlac, K Hadrava Vanova, N Bechmann, S Richter, J Folberth, ... Frontiers in Endocrinology 12, 589451, 2021 | 38 | 2021 |
| Hsa‐miR‐139‐5p is a prognostic thyroid cancer marker involved in HNRNPF‐mediated alternative splicing C Montero‐Conde, O Graña‐Castro, G Martín‐Serrano, ... International journal of cancer 146 (2), 521-530, 2020 | 38 | 2020 |
| Pheochromocytomas and paragangliomas: bypassing cellular respiration A Cascón, L Remacha, B Calsina, M Robledo Cancers 11 (5), 683, 2019 | 33 | 2019 |
| Concomitant medications and risk of chemotherapy‐induced peripheral neuropathy L Sánchez‐Barroso, M Apellaniz‐Ruiz, G Gutiérrez‐Gutiérrez, M Santos, ... The Oncologist 24 (8), e784-e792, 2019 | 32 | 2019 |
| In-vitro characterization of Abemaciclib pharmacology in ER+ breast cancer cell lines MJ Lallena, K Boehnke, R Torres, A Hermoso, J Amat, B Calsina, ... Cancer Research 75 (15_Supplement), 3101-3101, 2015 | 32 | 2015 |
| PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma JM Roldan‐Romero, B Beuselinck, M Santos, JF Rodriguez‐Moreno, ... International journal of cancer 146 (5), 1435-1444, 2020 | 31 | 2020 |
| Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma M Monteagudo, P Martínez, LJ Leandro-García, ÁM Martínez-Montes, ... Cancers 13 (19), 4758, 2021 | 24 | 2021 |
